Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
1.79M
-
Shares change
-
+76.7K
-
Total reported value, excl. options
-
$21.6M
-
Value change
-
+$928K
-
Number of buys
-
20
-
Number of sells
-
-10
-
Price
-
$12.10
Significant Holders of GYRE THERAPEUTICS, INC. - COM (GYRE) as of Q4 2024
40 filings reported holding GYRE - GYRE THERAPEUTICS, INC. - COM as of Q4 2024.
GYRE THERAPEUTICS, INC. - COM (GYRE) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.79M shares
.
Largest 10 shareholders include BlackRock, Inc. (532K shares), VANGUARD GROUP INC (322K shares), GEODE CAPITAL MANAGEMENT, LLC (304K shares), STATE STREET CORP (127K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (115K shares), NORTHERN TRUST CORP (103K shares), SBI Securities Co., Ltd. (101K shares), UBS Group AG (57.1K shares), GOLDMAN SACHS GROUP INC (26.4K shares), and MORGAN STANLEY (15.2K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.